Replies to post #167609 on NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

That's why Merck has switched 50% of their R&D to Keytruda trials, over 700 of them. They are reacting to something and I believe that something is that they couldn't kill NWBO or buy them on the cheap and see they're not dead and in fact are gaining strength. Keytruda sales are predicted to reach over $10 Billion by 2020. What giant drug company simply dumps projects to focus this hard on one drug? Why? I think they're trying to get so much momentum that they could advertise for Keytruda as a tried and true regimen for Cancers over this little start up NWBO without the same level of evidence. The machine of marketing has more power than reality; Americans are sheep and will follow shiny objects rather than one that actually works.